SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/0419B2B5745088E3715DF96476F3BCBBA8F5F2831139B249BE8DBA85D1963D3D3BD9B75DD5104725F539BE8E69C5BBC2>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/0419B2B5745088E3715DF96476F3BCBBA8F5F2831139B249BE8DBA85D1963D3D3BD9B75DD5104725F539BE8E69C5BBC2
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/0419B2B5745088E3715DF96476F3BCBBA8F5F2831139B249BE8DBA85D1963D3D3BD9B75DD5104725F539BE8E69C5BBC2
http://www.w3.org/2000/01/rdf-schema#comment
"These results showed that a modest suppression of Kv2.1 channels dramatically raises insulinotropic potency of GLP-1-based drugs."
xsd:string
http://purl.uniprot.org/uniprot/#_3119DA210216AFED3A68F77D49925908FF1FDA1975916503D8E06ADE7B3659C27511A859217BA9E3CEA69BB25A27392A
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/0419B2B5745088E3715DF96476F3BCBBA8F5F2831139B249BE8DBA85D1963D3D3BD9B75DD5104725F539BE8E69C5BBC2
http://purl.uniprot.org/uniprot/Q03717
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/0419B2B5745088E3715DF96476F3BCBBA8F5F2831139B249BE8DBA85D1963D3D3BD9B75DD5104725F539BE8E69C5BBC2
http://purl.uniprot.org/uniprot/#_Q03717-mappedCitation-25337656
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/0419B2B5745088E3715DF96476F3BCBBA8F5F2831139B249BE8DBA85D1963D3D3BD9B75DD5104725F539BE8E69C5BBC2